Research

St. Jude initiative aims to change the outlook for children with catastrophic neurological diseases.

Stimulating the adaptive immune response can improve outcomes for ALL treated with chemotherapy.

St. Jude research has advanced understanding of the immune response to SARS-CoV-2 infection and vaccination. Here is what the findings mean for you.

Muscle signaling provide clues for treatment of the muscle-wasting disorder cachexia, which affects cancer patients.

In his laboratory at St. Jude, Stephen Mack, PhD, is researching how metabolic and epigenetic pathways might be perturbed to help treat DIPG, a lethal childhood brain tumor.

St. Jude Children’s Research Hospital’s Department of Diagnostic Imaging is hosting their 3rd Annual Scientific Symposium, “Imaging Structure and Functions of the Hippocampus” on February 25.

Researchers are focusing on treatment-related pain as another way to reduce the risk of learning and memory problems in survivors of childhood leukemia.

St. Jude scientists have created an algorithm to help group T-cells by their function by evaluating two different types of data, T-cell receptor sequences and gene expression.

St. Jude biostatisticians have developed a new method for designing phase 2 clinical trials with a small sample size. The approach uses a mathematical model called Bayesian probability . The researchers created free software to implement the process.

St. Jude will host the virtual Bringing Chemistry to Medicine Symposium July 22–23. The inaugural event in 2020 prompted a researcher in India to become a visiting scientist at St. Jude. Register for the event.